Healthpeak Properties (NYSE:DOC) Given New $24.00 Price Target at Mizuho

Healthpeak Properties (NYSE:DOC) had its target price hoisted by Mizuho from $21.00 to $24.00 in a research note released on Monday morning, Marketbeat Ratings reports. The firm currently has an outperform rating on the real estate investment trust’s stock.

DOC has been the subject of a number of other research reports. Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Wells Fargo & Company lifted their target price on Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research report on Monday, June 1st. Robert W. Baird increased their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective on the stock. in a research note on Monday, May 11th. Finally, Royal Bank Of Canada lifted their price objective on shares of Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a report on Thursday, May 14th. Four equities research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. According to MarketBeat, Healthpeak Properties presently has an average rating of “Hold” and an average price target of $20.35.

Healthpeak Properties Stock Up 0.2%

Healthpeak Properties stock opened at $21.80 on Monday. The company has a market capitalization of $15.03 billion, a PE ratio of 68.15, a PEG ratio of 3.41 and a beta of 1.02. Healthpeak Properties has a 12-month low of $15.70 and a 12-month high of $22.04. The firm’s fifty day moving average is $19.65 and its 200 day moving average is $17.89. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The firm had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same period in the previous year, the firm posted $0.46 earnings per share. The business’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, sell-side analysts predict that Healthpeak Properties will post 1.75 EPS for the current fiscal year.

Insider Activity

In related news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.23% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Advocate Investing Services LLC bought a new position in Healthpeak Properties in the 4th quarter worth approximately $26,000. WPG Advisers LLC raised its position in Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 1,197 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Healthpeak Properties in the 2nd quarter worth about $33,000. Clearstead Advisors LLC increased its position in shares of Healthpeak Properties by 166.3% during the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after purchasing an additional 1,216 shares during the last quarter. Finally, Elyxium Wealth LLC purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at about $31,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.